BioLife Solutions, Inc. (NASDAQ:BLFS) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET

Company Participants

Troy Wichterman - Chief Financial Officer

Mike Rice - Chairman and Chief Executive Officer

Rod de Greef - President and Chief Operating Officer

Conference Call Participants

Thomas Flaten - Lake Street Capital Markets

Hannah Hefley - Stephens

Max Masucci - Cowen and Company

Suraj Kalia - Oppenheimer

Operator

Good day. My name is Chantel, and I'll be your conference operator today. At this time, I would like to welcome everyone to the BioLife Solutions Inc. Q2 2022 Earnings Conference Call. As a reminder, today's conference call is being recorded [Operator Instructions]. Thank you.

Troy Wichterman, Chief Financial Officer, you may begin your conference.

Troy Wichterman

Thank you, Chantel. Good afternoon, everyone and thank you for joining this call. Joining me on today's call are Mike Rice, Chairman and Chief Executive Officer; and Rod de Greef, President and Chief Operating Officer.

Earlier today, we issued a press release announcing our financial results and operational highlights for the second quarter of 2022. As a reminder, during this call, we may make certain projections and other forward-looking statements regarding future events or the future financial performance of the company or its acquisitions. These statements are subject to risks and uncertainties that may cause actual results to different materially from expectations. For a detailed discussion of the risks and uncertainties that affect the company's business and that qualify as forward looking statements, I refer you to our periodic and other public filings filed with the SEC.

Company projections and forward-looking statements are based on factors that are subject to change and therefore, these statements speak only as of the date they are given. The company assumes no obligation to update any projections or forward-looking statements except as required by law. During this call, we will speak to non-GAAP or adjusted results. Reconciliations of GAAP to non-GAAP or adjusted financial metrics are included in the press release we issued this afternoon. These non-GAAP or adjusted financial metrics should not be viewed as an alternative to GAAP. However, in light of our recent M&A activity, we believe that the use of non-GAAP or adjusted metrics provides investors with a clearer view of our current financial results when compared to prior periods.

Now I'd like to turn the call over to Mike Rice, Chairman and CEO of BioLife Solutions.

Mike Rice